American Journal of Infection Control

Streptococcus agalactiae or group B Streptococcus (GBS) is beta-hemolytic, catalase negative, gram-positive cocci, has been recognized for centuries and its relation to bloodstream infections with high epidemic rates of morbidity and mortality

Skin and skin structure infections (SSSIs) are a leading etiology of bacterial infections in the United States, many of which are caused by Staphylococcus aureus.1 In recent years, the emergence of community-associated methicillin-resistant

Invasive infections caused by carbapenem-resistant Enterobacterales (CRE) are of significant concern in healthcare settings. We assessed risk factors for CRE culture from a sterile site (invasive infection) compared to isolation from urine in a large

Non-pharmacological preventive measures (NPPMs) (e.g., avoiding travel, limiting physical contact with people outside of one's household, and maintaining a 1-2 meter distance between oneself and others when in public) are the primary strategies used

To adapt means “to become adjusted to new conditions.” Nothing could summarize infection prevention more succinctly since the start of the coronavirus disease 2019 (COVID-19) pandemic. The emerging science around the novel severe acute respiratory

SARS-CoV-2 is a highly infectious respiratory virus that is primarily transmitted by respiratory aerosols and droplets emitted during activities such as talking, breathing, and coughing.1, 2 In the past, aerosols have been defined as airborne

Urinary tract infections (UTIs) are the leading cause of nosocomial infections in the United States with the placement of indwelling urinary catheters as the major contributing factor (CAUTI)1. Urinary catheters are placed in 21-50% of hospitalized

Nonpharmaceutical Interventions (NPIs), such as facemask wearing, business and school lockdowns, and contact tracing, are effective tools to combat infectious diseases such as COVID-19 that have devastated people's lives around the globe1. When a

Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan, China, at the end of 2019 and rapidly became a pandemic in 2020 1. Healthcare providers (HCPs)

(CAUTI)